European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunization Documentation 111

European Pharmaceutical Review

JUNE 29, 2022

As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. To summarise, bioproduction hurdles include the necessity to be fast, agile and, not to be understated, able to deliver safe and effective vaccines worldwide.

Vaccines 98

Vaccines Documentation 98

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Complete Data Gathering. Outline Guiding and Segregation Principles.

Vaccines 97

Vaccines Compounding Documentation FDA 97

ISPE

AUGUST 29, 2022

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. laboratory notebooks, batch records, and technical reports) to submission documents (e.g., Smith, and R. Algorri, M.,

Documentation 52

Documentation FDA Communication Packaging 52

Hospital Pharmacy Europe

JANUARY 19, 2023

In 2016, the country’s first National Strategic Plan in Antimicrobial Resistance 2017–2021 was published. Accompanying leaflets for patients have been developed and also digital versions of the documentation. Thailand has had a number of projects to promote appropriate use of antimicrobials. By 2021, reductions of 15.2%

Community Pharmacies 98

Community Pharmacies Hospitals Communication Medical Schools 98

Hospital Pharmacy Europe

MAY 9, 2024

Over 70 graphics, including alternatives to handshakes and explanations of mRNA vaccines, were then created and published online by The Spinoff, a New Zealand news outlet. In microbiologically documented HAIs, 32% of microorganisms were resistant to antimicrobials. The survey revealed that approximately 4.3

Hospitals 52

Hospitals Communication Clinic Management Documentation 52